Damnacanthal, an effective inhibitor of LIM-kinase, inhibits cell migration and invasion

Molecular Biology of the Cell

Volumn 25, Issue 6, 2014, Pages 828-840

  Ohashia, Kazumasa ^a   Sampeia, Kaori ^a   Nakagawaa, Mami ^a   Uchiumia, Naoto ^a   Amanumaa, Tatsuya ^a   Aibab, Setsuya ^b   Oikawac, Masato ^c   Mizunoa, Kensaku ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; COFILIN; DAMNACANTHAL; HAPTEN; LIM KINASE; LIM KINASE 1; LIM KINASE 2 PROTEIN; P21 ACTIVATED KINASE 3; PROTEIN; PROTEIN KINASE LCK; PYRAZOLOPYRIMIDINE DERIVATIVE; RHO KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL DIVISION; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG SPECIFICITY; ENZYME INHIBITION; FLUORESCENCE IMAGING; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; IC 50; IN VITRO STUDY; LANGERHANS CELL; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TIME LAPSE IMAGING;

ACTINS; ANIMALS; ANTHRAQUINONES; CELL LINE, TUMOR; CELL MOVEMENT; CERCOPITHECUS AETHIOPS; CHEMOKINE CXCL12; COFILIN 1; COS CELLS; GENE EXPRESSION REGULATION; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; JURKAT CELLS; LANGERHANS CELLS; LIM KINASES; MICE; MICROSCOPY, FLUORESCENCE; PROTEIN KINASE INHIBITORS; PSEUDOPODIA; PYRIMIDINES; SIGNAL TRANSDUCTION;

EID: 84896298335     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E13-09-0540     Document Type: Article

References (55)

1. Aiba S, Katz SI (1990). Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J Immunol 145, 2791-2796. (Pubitemid 20382543)
2. Amano T, Tanabe K, Eto T, Narumiya S, Mizuno K (2001). LIM-kinase 2 induces formation of stress fibres, focal adhesions and membrane blebs, dependent on its activation by Rho-associated kinase-catalysed phosphorylation at threonine-505. Biochem J 354, 149-159. (Pubitemid 32183455)
3. Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard O, Caroni P (1998). Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393, 805-809. (Pubitemid 28299494)
4. Bamburg JR, Wiggan OP (2002). ADF/cofilin and actin dynamics in disease. Trends Cell Biol 12, 598-605. (Pubitemid 35461859)
5. Borhani DW, Calderwood DJ, Friedman MM, Hirst GC, Li B, Leung AK, McRae B, Ratnofsky S, Ritter K, Waegell W (2004). A-420983: a potent, orally active inhibitor of lck with efficacy in a model of transplant rejection. Bioorg Med Chem Lett 14, 2613-2616. (Pubitemid 38515713)
6. Bravo-Cordero JJ, Magalhaes MA, Eddy RJ, Hodgson L, Condeelis J (2013). Functions of cofilin in cell locomotion and invasion. Nat Rev Mol Cell Biol 14, 405-415.
7. Burchat AF, Calderwood DJ, Friedman MM, Hirst GC, Li B, Rafferty P, Ritter K, Skinner BS (2002). Pyrazolo[3,4-d]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck - a selectivity insight. Bioorg Med Chem Lett 12, 1687-1690. (Pubitemid 34569272)
8. Caughman SW, Sharrow SO, Shimada S, Stephany D, Mizuochi T, Rosenberg AS, Katz SI, Singer A (1986). Ia+ murine epidermal Langerhans cells are deficient in surface expression of the class I major histocompatibility complex. Proc Natl Acad Sci USA 83, 7438-7442. (Pubitemid 16000537)
9. Cohen P (2002). Protein kinases - the major drug targets of the twenty-first century. Nat Rev Drug Discov 1, 309-315.
10. Cumberbatch M, Dearman RJ, Griffiths CE, Kimber I (2000). Langerhans cell migration. Clin Exp Dermatol 25, 413-418.
11. Davila M, Frost AR, Grizzle WE, Chakrabarti R (2003). LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J Biol Chem 278, 36868-36875. (Pubitemid 37140021)
12. Edwards DC, Sanders LC, Bokoch GM, Gill GN (1999). Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol 1, 253-259. (Pubitemid 129495774)
13. Faltynek CR et al. (1995). Inhibition of T lymphocyte activation by a novel p56lck tyrosine kinase inhibitor. J. Enzyme Inhib 9, 111-122.
14. Harrison BA et al. (2009). Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma. J Med Chem 52, 6515-6518.
15. Horita Y, Ohashi K, Mukai M, Inoue M, Mizuno K (2008). Suppression of the invasive capacity of rat ascites hepatoma cells by knockdown of Slingshot or LIM kinase. J Biol Chem 283, 6013-6021.
16. Inngjerdingen M, Torgersen KM, Maghazachi AA (2002). Lck is required for stromal cell-derived factor 1 alpha (CXCL12)-induced lymphoid cell chemotaxis. Blood 99, 4318-4325. (Pubitemid 34627196)
17. Jayasuriya H, Koonchanok NM, Geahlen RL, McLaughlin JL, Chang CJ (1992). Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum. J Nat Prod 55, 696-698.
18. Kerppola TK (2009). Visualization of molecular interactions using bimolecular fluorescence complementation analysis: characteristics of protein fragment complementation. Chem Soc Rev 38, 2876-2886.
19. Kimber I, Cumberbatch M, Dearman RJ, Bhushan M, Griffiths CE (2000). Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br J Dermatol 142, 401-412. (Pubitemid 30159060)
20. Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M (2009). External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 206, 2937-2946.
21. Kusumoto S, Oikawa M (2001). Synthesis of glycolipid targets. In: Glycoscience. Chemistry and Chemical Biology I-III, ed. BO Fraser-Reid, K Tatsuta, and J Thiem, Heidelberg, Germany: Springer, 2107-2148.
22. Manetti F (2012a). LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators. Med Res Rev 32, 968-998.
23. Manetti F (2012b). Recent findings confirm LIM domain kinases as emerging target candidates for cancer therapy. Curr Cancer Drug Targets 12, 543-560.
24. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002). The protein kinase complement of the human genome. Science 298, 1912-1934. (Pubitemid 35425239)
25. Meberg PJ, Ono S, Minamide LS, Takahashi M, Bamburg JR (1998). Actin depolymerizing factor and cofilin phosphorylation dynamics: response to signals that regulate neurite extension. Cell Motil Cytoskeleton 39, 172-190. (Pubitemid 28079648)
26. Meyn MA 3rd, Smithgall TE (2008). Small molecule inhibitors of Lck: the search for specificity within a kinase family. Mini Rev Med Chem 8, 628-637.
27. Mishima T, Naotsuka M, Horita Y, Sato M, Ohashi K, Mizuno K (2010). LIM-kinase is critical for the mesenchymal-to-amoeboid cell morphological transition in 3D matrices. Biochem Biophys Res Commun 392, 577-581.
28. Mizuno K (2013). Signaling mechanisms and functional roles of cofilin phosphorylation and dephosphorylation. Cell Signal 25, 457-469.
29. Mizuno K, Okano I, Ohashi K, Nunoue K, Kuma K, Miyata T, Nakamura T (1994). Identification of a human cDNA encoding a novel protein kinase with two repeats of the LIM/double zinc finger motif. Oncogene 9, 1605-1612. (Pubitemid 24163386)
30. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A (2002). A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 20, 87-90. (Pubitemid 34044921)
31. Nishita M, Aizawa H, Mizuno K (2002). Stromal cell-derived factor 1alpha activates LIM kinase 1 and induces cofilin phosphorylation for T-cell chemotaxis. Mol Cell Biol 22, 774-783. (Pubitemid 34053057)
32. Nishita M, Tomizawa C, Yamamoto M, Horita Y, Ohashi K, Mizuno K (2005). Spatial and temporal regulation of cofilin activity by LIM kinase and Slingshot is critical for directional cell migration. J Cell Biol 171, 349-359. (Pubitemid 41540026)
33. Ohashi K, Fujiwara S, Watanabe T, Kondo H, Kiuchi T, Sato M, Mizuno K (2011). LIM kinase has a dual role in regulating lamellipodium extension by decelerating the rate of actin retrograde flow and the rate of actin polymerization. J Biol Chem 286, 36340-36351.
34. Ohashi K, Kiuchi T, Shoji K, Sampei K, Mizuno K (2012). Visualization of cofilin-actin and Ras-Raf interactions by bimolecular fluorescence complementation assays using a new pair of split Venus fragments. Biotechniques 52, 45-50.
35. Ohashi K, Nagata K, Maekawa M, Ishizaki T, Narumiya S, Mizuno K (2000). Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J Biol Chem 275, 3577-3582. (Pubitemid 30083067)
36. Oikawa M (2010). An improved synthesis of arylboronates toward twenty novel 1,3-disubstituted 4-amino-1h-pyrazolo[3,4-D]pyrimidine analogs. Heterocycles 81, 73-77.
37. Oikawa M, Ikoma M, Sasaki M (2005). Simultaneous accumulation of both skeletal and appendage-based diversities on tandem Ugi/Diels-Alder products. Tetrahedron Lett 46, 5863-5866. (Pubitemid 41073430)
38. Oikawa M, Ueno T, Oikawa H, Ichihara A (1995). Total synthesis of tautomycin. J Org Chem 60, 5048-5068.
39. Okano I, Hiraoka J, Otera H, Nunoue K, Ohashi K, Iwashita S, Hirai M, Mizuno K (1995). Identification and characterization of a novel family of serine/threonine kinases containing two N-terminal LIM motifs. J Biol Chem 270, 31321-31330. (Pubitemid 26012223)
40. Ono S (2007). Mechanism of depolymerization and severing of actin filaments and its significance in cytoskeletal dynamics. Int Rev Cytol 258, 1-82.
41. Parker C et al. (2010). Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. Lancet 376, 2009-2017.
42. Pollard TD, Borisy GG (2003). Cellular motility driven by assembly and disassembly of actin filaments. Cell 112, 453-465. (Pubitemid 36263079)
43. Prudent R et al. (2012). Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growth. Cancer Res 72, 4429-4439.
44. Ross-Macdonald P et al. (2008). Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors. Mol Cancer Ther 7, 3490-3498.
45. Saito A, Miyajima K, Akatsuka J, Kondo H, Mashiko T, Kiuchi T, Ohashi K, Mizuno K (2013). CaMKII beta-mediated LIM-kinase activation plays a crucial role in BDNF-induced neuritogenesis. Genes Cells 18, 533-543.
46. Schlessinger J, Lemmon MA (2003). SH2 and PTB domains in tyrosine kinase signaling. Sci STKE 2003, RE12.
47. Scott RW et al. (2010). LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells. J Cell Biol 191, 169-185.
48. Scott RW, Olson MF (2007). LIM kinases: function, regulation and association with human disease. J Mol Med (Berl) 85, 555-568. (Pubitemid 46870893)
49. Shoji K, Ohashi K, Sampei K, Oikawa M, Mizuno K (2012). Cytochalasin D acts as an inhibitor of the actin-cofilin interaction. Biochem Biophys Res Commun 424, 52-57.
50. Sleebs BE, Nikolakopoulos G, Street IP, Falk H, Baell JB (2011). Identification of 5,6-substituted 4-aminothieno[2,3-d]pyrimidines as LIMK1 inhibitors. Bioorg Med Chem Lett 21, 5992-5994.
51. Toshima J, Toshima JY, Amano T, Yang N, Narumiya S, Mizuno K (2001). Cofilin phosphorylation by protein kinase testicular protein kinase 1 and its role in integrin-mediated actin reorganization and focal adhesion formation. Mol Biol Cell 12, 1131-1145. (Pubitemid 33052004)
52. Tzivion G, Avruch J (2002). 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J Biol Chem 277, 3061-3064. (Pubitemid 34953163)
53. Wang W, Eddy R, Condeelis J (2007). The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 7, 429-440. (Pubitemid 46809168)
54. Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K, Nishida E, Mizuno K (1998). Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 393, 809-812. (Pubitemid 28299495)
55. Yoshioka K, Foletta V, Bernard O, Itoh K (2003). A role for LIM kinase in cancer invasion. Proc Natl Acad Sci USA 100, 7247-7252. (Pubitemid 36706424)